DEKEMA Restructures Its Executive Management

With the departure of Mr. Dr. Miller from the company and the executive board, DEKEMA is setting the course for the next phase of the company’s development.

The new executive team consists of Mr. Dr. Yan as CEO, Ms. König as COO, and Mr. Weist as CTO. With clearly defined responsibilities and a strong combination of strategic, operational, and technological expertise, the company aims to consistently continue its successful growth.

Mr. Dr. Miller has had a significant impact on DEKEMA for over 25 years and has played a decisive role in shaping the company’s development. Even after his departure, he will remain connected to DEKEMA and will continue to serve the company in an advisory capacity.

“DEKEMA is exceptionally well-positioned to successfully continue on its current path. I am pleased to hand over responsibility to a strong leadership team and to support the company’s future development from an advisory perspective.” explains Dr. Miller.

With its new leadership structure, DEKEMA combines continuity with a clear focus on the future. The goal is to further expand the company’s technological strength, consistently refine operational processes, and sustainably strengthen DEKEMA’s position in the international market.